Consumer Health Cancer / Immunology
Merck Broadens Colorectal Cancer Portfolio via Licensing Deal with Inspirna
First-in-class ompenaclid (RGX-202) currently in Phase II development for RAS-mutated advanced or metastatic colorectal cancer Collaboration includes ex...
January 05, 2024 | News
Clover's SCB-219M Shows Positive Phase I Results for Chemotherapy-Induced Thrombocytopenia (CIT) Treatment
--All CIT patients maintained platelet counts >75 x 109/L at 1-week following chemotherapy plus a single dose of SCB-219M, with durable responses t...
December 29, 2023 | News
RemeGen's RC88 Granted FDA IND Approval for Platinum-Resistant Ovarian Cancer
The open-label, randomized, dose optimization phase 2 study aims to enroll participants in multiple countries to further clarify the optimal dosage...
December 29, 2023 | News
BioCity Doses First Patient in Phase Ib/II Trial of BC3402 Anti-TIM-3 mAb with IMFINZI for Advanced Hepatocellular Carcinoma
The study is being conducted at Zhongshan Hospital with Prof. Jia Fan as the principal investigator. Dr. Fan is a world-renowned liver cancer sur...
December 21, 2023 | News
Advancing Lung Cancer Treatment: Insights from Professor Benjamin Solomon on the ALINA Study and the Future of ALK-Positive NSCLC
In an exclusive BioPharma APAC interview, Professor Benjamin Solomon, a distinguished Medical Oncologist at the Peter MacCallum Cancer Centre, Australia, a...
December 18, 2023 | News
SeekIn and OncoInv Partner to Enhance Global Access to Cancer Detection Tests and Address Disparities in Cancer Care
SeekIn Inc, a leader in blood-based cancer early detection and monitoring technology, announced a strategic collaboration with Oncolnv, a fully-owned affil...
December 15, 2023 | News
Singapore Introduces New Treatment for Metastatic Colorectal Cancer Patients with BRAFV600E Mutation
Pierre Fabre Singapore receives approval from the Ministry of Health (“MOH”), Singapore, for the listing of BRAFTOVI on the Cancer Drug L...
December 15, 2023 | News
Virtual twin to improve treatment with cancer immunotherapies
In recent years, cancer immunotherapies have established themselves as a further pillar of medical oncology alongside traditional treatment options (surger...
December 14, 2023 | News
Inside the World of Cell Therapies: Illuminating the Future of Cancer Care
The Rise of Cell Therapies in Cancer Care Recent years have witnessed significant strides in the development and application of cell therapies for cancer ...
December 13, 2023 | News
Examining Financial Ruin, Advocating for Change, and Fostering Collaboration in Cancer Care Economics Across the Asia Pacific Region
In a recent email interview with BioPharma APAC, Dr. Nirmala Bhoo-Pathy, a distinguished Professor of (Clinical) Epidemiology at the Faculty of Medicine, U...
December 13, 2023 | News
Combatting Cancer Disparities: Addressing Challenges and Expanding Access to Care in Low- and Middle-Income Countries
In an exclusive email interview with BioPharma APAC, Carmen Auste, the CEO of Cancer Warriors Foundation Philippines and Vice President of Cancer Coalition...
December 13, 2023 | News
First Patient Dosed in U.S. Access Program for Telix's TLX250-CDx Kidney Cancer Imaging
The patient was dosed at ARA Diagnostic Imaging at Austin Radiological Association in Austin (TX, U.S.) following U.S. Food and Drug Administrati...
December 12, 2023 | News
Zhongchao Inc. Partners with Public Health Foundation for Cancer Treatment Advancements
The Project offers free Doxorubicin Hydrochloride Liposome Injections to low-income patients with breast cancer, lymphoma, Kaposi's sarcoma, ovarian cancer...
December 12, 2023 | News
Lunit Advances to Stage 2 of Australia's National Breast Cancer Screening Project
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced its progression to the second st...
December 12, 2023 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
